Friday, April 9, 2021

Vaccitech, startup behind Oxford's COVID-19 vaccine, files for US IPO

Biotech startup Vaccitech Plc, which owns the technology behind the COVID-19 vaccine developed by Oxford University and AstraZeneca Plc, filed for a US initial public offering. https://ift.tt/3s1jJAx

No comments:

Post a Comment

UK publisher Bloomsbury says it is among the beneficiaries of the $1.5B Anthropic settlement; 14,087 of its titles are covered, with ~$3K in compensation each (Anushka Chourasia/Reuters)

Anushka Chourasia / Reuters : UK publisher Bloomsbury says it is among the beneficiaries of the $1.5B Anthropic settlement; 14,087 of its...